Join
Live feed
·
PRReleasevia Quantisnow
Bicycle Therapeutics plc logo

Bicycle Therapeutics Announces Interim BT8009 Phase I Clinical Trial Results at the 2022 AACR Annual Meeting

ByQuantisnow·Wall Street's wire, on your screen.
BCYC· Bicycle Therapeutics plc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BCYC (Bicycle Therapeutics plc) and more on Quantisnow.